Clinical and Radiographic Assessment of Periodontal Status Among Patients with Post-COVID Mucormycosis: A Cross-sectional Study

Overview

Journal J Indian Soc Periodontol

Date 2023 Aug 18

PMID 37593554

Authors

Muthukumaraswamy Arunachalam

Rajakumari Natarajan

Malathi Krishnamurthi

Ramesh Kumar Gopalakrishnan

Affiliations

Soon will be listed here.

Abstract

Background: An escalation in cases of rhinomaxillary mucormycosis among post-COVID patients is being reported. However, there is limited information about periodontal features in mucormycosis cases. This study explored the periodontal signs and symptoms among post-COVID mucormycosis individuals.

Materials And Methods: This cross-sectional study was carried out with a total of 25 post-COVID mucormycosis patients attending tertiary care public teaching hospital. Clinical and radiographic assessments were done.

Results: An elevation in mean probing pocket depth (PPD) up to 6.21 ± 2.7 mm was noted. Nearly 16%-40% of patients had Miller's Grade III mobility in the affected site. Forty-four per cent had localized single or multiple abscess, 40% had palatal swelling, 32% had necrosis of soft tissue and bone exposure, and 52% had maxillary dentoalveolar segmental mobility in the affected site. Radiographic examination revealed varying stages of interdental bone loss.

Conclusion: The present study observed an increase in mobility and mean PPD which did not commiserate with interdental bone loss in the affected maxillary region.

References

Papapanou P, Sanz M, Buduneli N, Dietrich T, Feres M, Fine D . Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol. 2018; 45 Suppl 20:S162-S170. DOI: 10.1111/jcpe.12946. View

Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H . Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8):782-793. DOI: 10.1001/jama.2020.12839. View

Smith H, Kirchner J . Cerebral mucormycosis; a report of three cases. AMA Arch Otolaryngol. 1958; 68(6):715-26. DOI: 10.1001/archotol.1958.00730020739010. View

Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B . Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020; 12(1):9. PMC: 7054527. DOI: 10.1038/s41368-020-0075-9. View

Bohn M, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K . Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression. Physiology (Bethesda). 2020; 35(5):288-301. PMC: 7426542. DOI: 10.1152/physiol.00019.2020. View

Pizzo P . Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med. 1993; 328(18):1323-32. DOI: 10.1056/NEJM199305063281808. View

Sterne J, Murthy S, Diaz J, Slutsky A, Villar J, Angus D . Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020; 324(13):1330-1341. PMC: 7489434. DOI: 10.1001/jama.2020.17023. View

Ferguson A . Rhinocerebral mucormycosis acquired after a short course of prednisone therapy. J Am Osteopath Assoc. 2007; 107(11):491-3. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 588(7836):E6. PMC: 9744119. DOI: 10.1038/s41586-020-2951-z. View

10.

Yuki K, Fujiogi M, Koutsogiannaki S . COVID-19 pathophysiology: A review. Clin Immunol. 2020; 215:108427. PMC: 7169933. DOI: 10.1016/j.clim.2020.108427. View

11.

Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q . Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020; 367(6485):1444-1448. PMC: 7164635. DOI: 10.1126/science.abb2762. View

12.

Morrison V, McGlave P . Mucormycosis in the BMT population. Bone Marrow Transplant. 1993; 11(5):383-8. View

13.

Roden M, Zaoutis T, Buchanan W, Knudsen T, Sarkisova T, Schaufele R . Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41(5):634-53. DOI: 10.1086/432579. View

14.

Liu L, Wei Q, Alvarez X, Wang H, Du Y, Zhu H . Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol. 2011; 85(8):4025-30. PMC: 3126125. DOI: 10.1128/JVI.02292-10. View

15.

Cavezzi A, Troiani E, Corrao S . COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. 2020; 10(2):1271. PMC: 7267810. DOI: 10.4081/cp.2020.1271. View

16.

Mehta P, Fajgenbaum D . Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate. Curr Opin Rheumatol. 2021; 33(5):419-430. PMC: 8373392. DOI: 10.1097/BOR.0000000000000822. View

17.

Wu C, Lidsky P, Xiao Y, Lee I, Cheng R, Nakayama T . SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Cell Metab. 2021; 33(8):1565-1576.e5. PMC: 8130512. DOI: 10.1016/j.cmet.2021.05.013. View

18.

Wenzhong L, Hualan L . COVID-19: captures iron and generates reactive oxygen species to damage the human immune system. Autoimmunity. 2021; 54(4):213-224. PMC: 8074649. DOI: 10.1080/08916934.2021.1913581. View

19.

Ibrahim A, Spellberg B, Edwards Jr J . Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008; 21(6):620-5. PMC: 2773686. DOI: 10.1097/QCO.0b013e3283165fd1. View

20.

John T, Jacob C, Kontoyiannis D . When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J Fungi (Basel). 2021; 7(4). PMC: 8071133. DOI: 10.3390/jof7040298. View